- Home
- LIN vs MRK Comparison
LIN vs MRK Comparison
Compare LIN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIN
- MRK
- Stock Information
- Founded
- LIN 1879
- MRK 2000
- Country
- LIN United Kingdom
- MRK United States
- Employees
- LIN N/A
- MRK N/A
- Industry
- LIN Major Chemicals
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- LIN Industrials
- MRK Health Care
- Exchange
- LIN Nasdaq
- MRK Nasdaq
- Market Cap
- LIN 217.0B
- MRK 218.8B
- IPO Year
- LIN N/A
- MRK N/A
- Fundamental
- Price
- LIN $421.13
- MRK $86.04
- Analyst Decision
- LIN Buy
- MRK Buy
- Analyst Count
- LIN 12
- MRK 15
- Target Price
- LIN $505.10
- MRK $105.29
- AVG Volume (30 Days)
- LIN 2.6M
- MRK 10.2M
- Earning Date
- LIN 10-31-2025
- MRK 10-30-2025
- Dividend Yield
- LIN 1.43%
- MRK 3.76%
- EPS Growth
- LIN 13.37
- MRK 58.06
- EPS
- LIN 14.94
- MRK 7.56
- Revenue
- LIN $33,504,000,000.00
- MRK $64,235,000,000.00
- Revenue This Year
- LIN $3.68
- MRK $1.82
- Revenue Next Year
- LIN $5.54
- MRK $5.10
- P/E Ratio
- LIN $28.15
- MRK $11.42
- Revenue Growth
- LIN 1.45
- MRK 1.68
- 52 Week Low
- LIN $408.65
- MRK $73.31
- 52 Week High
- LIN $486.38
- MRK $105.07
- Technical
- Relative Strength Index (RSI)
- LIN 31.05
- MRK 52.44
- Support Level
- LIN $409.00
- MRK $82.01
- Resistance Level
- LIN $454.80
- MRK $88.30
- Average True Range (ATR)
- LIN 6.90
- MRK 1.97
- MACD
- LIN -1.68
- MRK -0.25
- Stochastic Oscillator
- LIN 26.48
- MRK 59.22
About LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2024.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).